Invention Grant
- Patent Title: Stabalised 99mTc compositions
-
Application No.: US11721064Application Date: 2005-10-14
-
Publication No.: US09694092B2Publication Date: 2017-07-04
- Inventor: Ole Kristian Hjelstuen , Grethe Karin Martinussen , Gry Stensrud
- Applicant: Ole Kristian Hjelstuen , Grethe Karin Martinussen , Gry Stensrud
- Applicant Address: GB
- Assignee: GE Healthcare Limited
- Current Assignee: GE Healthcare Limited
- Current Assignee Address: GB
- Agency: Wood IP LLC
- Priority: GB0427392.6 20041215
- International Application: PCT/GB2005/003975 WO 20051014
- International Announcement: WO2006/064175 WO 20060622
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61M36/14 ; A61K51/04

Abstract:
The present invention relates to stabilised 99mTc radiopharmaceutical compositions of the ligand tetrofosmin, which include an ascorbic acid or ascorbate radioprotectant, in the absence of an antimicrobial preservative. The invention also provides lyophilised kits suitable for the bulk preparation of multiple unit patient doses of 99mTc-tetrofosmin metal complexes. Also disclosed are unit doses of 99mTc-tetrofosmin, together with processes for preparing such unit doses from the lyophilised bulk vial.
Public/Granted literature
- US20110008252A9 STABALISED 99MTC COMPOSITIONS Public/Granted day:2011-01-13
Information query